Altered expression of telomere-associated genes in leukocytes among BRCA1 and BRCA2 carriers

Hiromi Tanaka, Elizabeth A. Phipps, Ting Wei, Xi Wu, Chirayu Goswami, Yunlong Liu, George W. Sledge, Lida Mina, Brittney-Shea Herbert

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Telomere dysfunction resulting from telomere shortening and deregulation of shelterin components has been linked to the pathogenesis of age-related disorders, including cancer. Recent evidence suggests that BRCA1/2 (BRCA1 and BRCA2) tumor suppressor gene products play an important role in telomere maintenance. Although telomere shortening has been reported in BRCA1/2 carriers, the direct effects of BRCA1/2 haploinsufficiency on telomere maintenance and predisposition to cancer development are not completely understood. In this study, we assessed the telomere-associated and telomere-proximal gene expression profiles in peripheral blood leukocytes from patients with a BRCA1 or BRCA2 mutation, compared to samples from sporadic and familial breast cancer individuals. We found that 25 genes, including TINF2 gene (a negative regulator of telomere length), were significantly differentially expressed in BRCA1 carriers. Leukocyte telomere length analysis revealed that BRCA1/2 carriers had relatively shorter telomeres than healthy controls. Further, affected BRCA1/2 carriers were well differentiated from unaffected BRCA1/2 carriers by the expression of telomere-proximal genes. Our results link BRCA1/2 haploinsufficiency to changes in telomere length, telomere-associated as well as telomere-proximal gene expression. Thus, this work supports the effect of BRCA1/2 haploinsufficiency in the biology underlying telomere dysfunction in cancer development. Future studies evaluating these findings will require a large study population.

Original languageEnglish (US)
JournalMolecular Carcinogenesis
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Telomere
Leukocytes
Genes
Haploinsufficiency
Telomere Shortening
Maintenance
Neoplasms
Tumor Suppressor Genes
Transcriptome

Keywords

  • BRCA1/2
  • Breast cancer
  • Gene expression
  • Haploinsufficiency
  • Telomere length

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Altered expression of telomere-associated genes in leukocytes among BRCA1 and BRCA2 carriers. / Tanaka, Hiromi; Phipps, Elizabeth A.; Wei, Ting; Wu, Xi; Goswami, Chirayu; Liu, Yunlong; Sledge, George W.; Mina, Lida; Herbert, Brittney-Shea.

In: Molecular Carcinogenesis, 01.01.2018.

Research output: Contribution to journalArticle

@article{b0f190b115c046a09723a9a8ddc5a6a6,
title = "Altered expression of telomere-associated genes in leukocytes among BRCA1 and BRCA2 carriers",
abstract = "Telomere dysfunction resulting from telomere shortening and deregulation of shelterin components has been linked to the pathogenesis of age-related disorders, including cancer. Recent evidence suggests that BRCA1/2 (BRCA1 and BRCA2) tumor suppressor gene products play an important role in telomere maintenance. Although telomere shortening has been reported in BRCA1/2 carriers, the direct effects of BRCA1/2 haploinsufficiency on telomere maintenance and predisposition to cancer development are not completely understood. In this study, we assessed the telomere-associated and telomere-proximal gene expression profiles in peripheral blood leukocytes from patients with a BRCA1 or BRCA2 mutation, compared to samples from sporadic and familial breast cancer individuals. We found that 25 genes, including TINF2 gene (a negative regulator of telomere length), were significantly differentially expressed in BRCA1 carriers. Leukocyte telomere length analysis revealed that BRCA1/2 carriers had relatively shorter telomeres than healthy controls. Further, affected BRCA1/2 carriers were well differentiated from unaffected BRCA1/2 carriers by the expression of telomere-proximal genes. Our results link BRCA1/2 haploinsufficiency to changes in telomere length, telomere-associated as well as telomere-proximal gene expression. Thus, this work supports the effect of BRCA1/2 haploinsufficiency in the biology underlying telomere dysfunction in cancer development. Future studies evaluating these findings will require a large study population.",
keywords = "BRCA1/2, Breast cancer, Gene expression, Haploinsufficiency, Telomere length",
author = "Hiromi Tanaka and Phipps, {Elizabeth A.} and Ting Wei and Xi Wu and Chirayu Goswami and Yunlong Liu and Sledge, {George W.} and Lida Mina and Brittney-Shea Herbert",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/mc.22773",
language = "English (US)",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Altered expression of telomere-associated genes in leukocytes among BRCA1 and BRCA2 carriers

AU - Tanaka, Hiromi

AU - Phipps, Elizabeth A.

AU - Wei, Ting

AU - Wu, Xi

AU - Goswami, Chirayu

AU - Liu, Yunlong

AU - Sledge, George W.

AU - Mina, Lida

AU - Herbert, Brittney-Shea

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Telomere dysfunction resulting from telomere shortening and deregulation of shelterin components has been linked to the pathogenesis of age-related disorders, including cancer. Recent evidence suggests that BRCA1/2 (BRCA1 and BRCA2) tumor suppressor gene products play an important role in telomere maintenance. Although telomere shortening has been reported in BRCA1/2 carriers, the direct effects of BRCA1/2 haploinsufficiency on telomere maintenance and predisposition to cancer development are not completely understood. In this study, we assessed the telomere-associated and telomere-proximal gene expression profiles in peripheral blood leukocytes from patients with a BRCA1 or BRCA2 mutation, compared to samples from sporadic and familial breast cancer individuals. We found that 25 genes, including TINF2 gene (a negative regulator of telomere length), were significantly differentially expressed in BRCA1 carriers. Leukocyte telomere length analysis revealed that BRCA1/2 carriers had relatively shorter telomeres than healthy controls. Further, affected BRCA1/2 carriers were well differentiated from unaffected BRCA1/2 carriers by the expression of telomere-proximal genes. Our results link BRCA1/2 haploinsufficiency to changes in telomere length, telomere-associated as well as telomere-proximal gene expression. Thus, this work supports the effect of BRCA1/2 haploinsufficiency in the biology underlying telomere dysfunction in cancer development. Future studies evaluating these findings will require a large study population.

AB - Telomere dysfunction resulting from telomere shortening and deregulation of shelterin components has been linked to the pathogenesis of age-related disorders, including cancer. Recent evidence suggests that BRCA1/2 (BRCA1 and BRCA2) tumor suppressor gene products play an important role in telomere maintenance. Although telomere shortening has been reported in BRCA1/2 carriers, the direct effects of BRCA1/2 haploinsufficiency on telomere maintenance and predisposition to cancer development are not completely understood. In this study, we assessed the telomere-associated and telomere-proximal gene expression profiles in peripheral blood leukocytes from patients with a BRCA1 or BRCA2 mutation, compared to samples from sporadic and familial breast cancer individuals. We found that 25 genes, including TINF2 gene (a negative regulator of telomere length), were significantly differentially expressed in BRCA1 carriers. Leukocyte telomere length analysis revealed that BRCA1/2 carriers had relatively shorter telomeres than healthy controls. Further, affected BRCA1/2 carriers were well differentiated from unaffected BRCA1/2 carriers by the expression of telomere-proximal genes. Our results link BRCA1/2 haploinsufficiency to changes in telomere length, telomere-associated as well as telomere-proximal gene expression. Thus, this work supports the effect of BRCA1/2 haploinsufficiency in the biology underlying telomere dysfunction in cancer development. Future studies evaluating these findings will require a large study population.

KW - BRCA1/2

KW - Breast cancer

KW - Gene expression

KW - Haploinsufficiency

KW - Telomere length

UR - http://www.scopus.com/inward/record.url?scp=85040042656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040042656&partnerID=8YFLogxK

U2 - 10.1002/mc.22773

DO - 10.1002/mc.22773

M3 - Article

C2 - 29240257

AN - SCOPUS:85040042656

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

ER -